"Spreisel"( dasatinib): price, analogues. Where to Buy a Sprice
The preparation "Spricel" oncologists is prescribed to patients with chronic myelogenous leukemia and acute lymphoblastic leukemia. This drug belongs to the group of protein kinase inhibitors.
"Spricele" reviews get positive. Doctors and patients note the high effectiveness of the drug, but many complain about the high cost. So, in Moscow pharmacies on "Spriceil" the price was fixed within the range from 98 000 to 192 000. The difference is due to differences in dosage. Treatment with the help of such a tool by far not everyone, and yet the way out is.
Generic of the preparation
Despite the fact that the price for many patients may seem quite unbearable on the original "Spricele", one should not despair. There is a generic drug, the cost of which is several times lower.
Generic is a drug that is produced using the same formulation as the original remedy. In addition, it has a similar high efficiency. Then why is the generic cheaper? This is because, in its production, the issuing company does not develop a pharmacological formula on its own. She also does not conduct clinical trials( they have already been carried out by a firm that launched the original) and does not develop an advertising campaign. As a result, many patients have the opportunity to purchase life-saving drugs at an affordable price.
Where to buy "Sprite" cheaper than
If you or your loved ones in myelo leukemia therapy have recommended the use of the drug we are considering, contact the Internet resource
Before you leave an application for the purchase of the drug, prepare documents confirming the need for treatment with this particular remedy. This is required by site rules.
"Spriceel": instruction for use
Tablets are recommended to be swallowed whole, not liquid, squeezed with water. Take the medication once a day - in the morning or in the evening.
The initial recommended dose for patients with chronic myelogenous leukemia is 100 mg. In other cases, the dosage increases to 140 mg. However, remember that appoint a drug and choose the right dosage should only be a doctor.
"Spriceil" may not be prescribed to all patients with myeloid leukemia. It is not recommended for use in the treatment of the following categories of patients:
- of pregnant and lactating women;
- children and adolescents;
- with individual intolerance of the main active substance - dasatinib.
For hepatic insufficiency, the drug should be administered with caution.
Possible side effects of
Taking the drug may cause:
- upper respiratory tract infection;
- fluid retention in the body;
- pain in the digestive tract;
- skin rash;
- shortness of breath;
If these symptoms occur, the attending physician can adjust the dosage of the remedy.